BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours.

导出 OA

翻译打印收藏纠错

第一作者： Pashtoon Murtaza,Kasi

第一单位： Weill Cornell Medicine, New York City, New York, USA.

作者： Pashtoon Murtaza,Kasi ^[1] ; Sakti,Chakrabarti ^[2] ; Sarah,Sawyer ^[3] ; Michael,Krainock ^[3] ; Andrew,Poklepovic ^[4] ; George,Ansstas ^[5] ; Minu,Maninder ^[3] ; Meenakshi,Malhotra ^[3] ; Joe,Ensor ^[3] ; Ling,Gao ^[6] ; Zeynep,Eroglu ^[7] ; Sascha,Ellers ^[3] ; Paul,Billings ^[3] ; Angel,Rodriguez ^[3] ; Alexey,Aleshin ^[8]

作者单位： Weill Cornell Medicine, New York City, New York, USA. ^[1] Medical College of Wisconsin, Milwaukee, Wisconsin, USA. ^[2] Natera Inc, Austin, Texas, USA. ^[3] VCU Health System Massey Cancer Center, Richmond, Virginia, USA. ^[4] Washington University, St Louis, Missouri, USA. ^[5] VA Long Beach Healthcare, Long Beach, California, USA.;University of California Irvine, Irvine, California, USA. ^[6] Moffitt Cancer Center, Tampa, Florida, USA. ^[7] Natera Inc, Austin, Texas, USA aaleshin@natera.com. ^[8]

关键词 dermatological tumours gastrointestinal tumours oncology respiratory tract tumours

主题词人类(Humans);免疫因子类(Immunologic Factors);免疫疗法(Immunotherapy);多中心研究(主题)(Multicenter Studies as Topic);肿瘤(Neoplasms);前瞻性研究(Prospective Studies)

DOI 10.1136/bmjopen-2021-060342

PMID 35636789

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交